Vital Images is highlighting the benefits of its Vitrea solutions as it participates in the 12th Annual Scientific Meeting of the Society of Cardiovascular Computed Tomography (SCCT), July 6-9 in Washington, D.C. The company will focus on the advantages of its Vitrea Advanced Visualization Version 7.

Stephen N. Birrell, M.D., Ph.D., presented breakthrough findings into the reduction of mammographic breast density at the 8th International Breast Densitometry and Cancer Risk Assessment Conference in San Francisco. The conference, co-chaired by University of California San Francisco and Karolinska Institutet, included presentations and posters by researchers from institutions across the world, including the Mayo Clinic and Queen Mary University of London.

In a bid to make the world's first while-you-wait test for breast cancer, European scientists are developing a comfortable hemispherical bowl lined with laser sources and ultrasound detectors with the potential to reduce the stages in spotting the disease into a single appointment.

June 27, 2017 — Senate Majority Leader Mitch McConnell (R-Ky.) and fellow Republicans announced Tuesday that a final ...

Fujitsu Laboratories Ltd. announced development of a technology to retrieve similar disease cases from a computed tomography (CT) database of previously taken images. The technology, jointly developed with Fujitsu R&D Center Co. Ltd., works by retrieving similar cases of abnormal shadows expanding in a three-dimensional manner.

June 26, 2017 — A recent study appears to confirm the recommendations of the National Comprehensive Cancer Network (NCCN ...

RamSoft announced a new partnership with Peru-based medical imaging equipment provider, Gamel. With RamSoft’s PowerServer RIS/PACS (radiology information system/picture archiving and communication system) and Gateway Viewer Mini PACS, Gamel’s clients will benefit from improved service accuracy, increased patient turnaround times and optimal patient care.

A new article published by JAMA Oncology compares outcomes for combined mammography and magnetic resonance imaging (MRI) or ultrasonography screenings for new breast cancers in women who have previously undergone breast conservation surgery and radiotherapy for breast cancer initially diagnosed at 50 or younger.